Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice

Inge Søkilde Pedersen, Peter Dervan, Alo McGoldrick, Michéle Harrison, Frederique Ponchel, Valerie Speirs, John D. Isaacs, Thomas Gorey, Amanda McCann

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Neuraminidase initiates the hydrolysis of sialo-glycoconjugates by removing their terminal sialic acid residues. In humans, primary or secondary deficiency of this enzyme leads to two clinically similar neurodegenerative lysosomal storage disorders: sialidosis and galactosialidosis (GS). Mice nullizygous at the Neu1 locus develop clinical abnormalities reminiscent of early-onset sialidosis in children, including severe nephropathy, progressive edema, splenomegaly, kyphosis and urinary excretion of sialylated oligosaccharides. Although the sialidosis mouse model shares clinical and histopathological features with GS mice and GS patients, we have identified phenotypic abnormalities that seem specific for sialidosis mice. These include progressive deformity of the spine, high incidence of premature death, age-related extramedullary hematopoiesis, and lack of early degeneration of cerebellar Purkinje cells. The differences and similarities identified in these sialidosis and GS mice may help to better understand the pathophysiology of these diseases in children and to identify more targeted therapies for each of these diseases.

Original languageEnglish
JournalHuman Molecular Genetics
Volume11
Issue number12
Publication statusPublished - 1 Jun 2002

Fingerprint

Mucolipidoses
Nervous System Malformations
Extramedullary Hematopoiesis
Kyphosis
Premature Mortality
Glycoconjugates
Purkinje Cells
Splenomegaly
Neuraminidase
N-Acetylneuraminic Acid
Oligosaccharides
Edema
Spine
Hydrolysis
Neuraminidase deficiency with beta-galactosidase deficiency
Incidence
Enzymes

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Genetics(clinical)

Cite this

Pedersen, I. S., Dervan, P., McGoldrick, A., Harrison, M., Ponchel, F., Speirs, V., ... McCann, A. (2002). Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice. Human Molecular Genetics, 11(12).

Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice. / Pedersen, Inge Søkilde; Dervan, Peter; McGoldrick, Alo; Harrison, Michéle; Ponchel, Frederique; Speirs, Valerie; Isaacs, John D.; Gorey, Thomas; McCann, Amanda.

In: Human Molecular Genetics, Vol. 11, No. 12, 01.06.2002.

Research output: Contribution to journalArticle

Pedersen, IS, Dervan, P, McGoldrick, A, Harrison, M, Ponchel, F, Speirs, V, Isaacs, JD, Gorey, T & McCann, A 2002, 'Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice', Human Molecular Genetics, vol. 11, no. 12.
Pedersen, Inge Søkilde ; Dervan, Peter ; McGoldrick, Alo ; Harrison, Michéle ; Ponchel, Frederique ; Speirs, Valerie ; Isaacs, John D. ; Gorey, Thomas ; McCann, Amanda. / Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice. In: Human Molecular Genetics. 2002 ; Vol. 11, No. 12.
@article{ff1059e839564ab48de814f9b6c909d8,
title = "Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice",
abstract = "Neuraminidase initiates the hydrolysis of sialo-glycoconjugates by removing their terminal sialic acid residues. In humans, primary or secondary deficiency of this enzyme leads to two clinically similar neurodegenerative lysosomal storage disorders: sialidosis and galactosialidosis (GS). Mice nullizygous at the Neu1 locus develop clinical abnormalities reminiscent of early-onset sialidosis in children, including severe nephropathy, progressive edema, splenomegaly, kyphosis and urinary excretion of sialylated oligosaccharides. Although the sialidosis mouse model shares clinical and histopathological features with GS mice and GS patients, we have identified phenotypic abnormalities that seem specific for sialidosis mice. These include progressive deformity of the spine, high incidence of premature death, age-related extramedullary hematopoiesis, and lack of early degeneration of cerebellar Purkinje cells. The differences and similarities identified in these sialidosis and GS mice may help to better understand the pathophysiology of these diseases in children and to identify more targeted therapies for each of these diseases.",
author = "Pedersen, {Inge S{\o}kilde} and Peter Dervan and Alo McGoldrick and Mich{\'e}le Harrison and Frederique Ponchel and Valerie Speirs and Isaacs, {John D.} and Thomas Gorey and Amanda McCann",
year = "2002",
month = "6",
day = "1",
language = "English",
volume = "11",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice

AU - Pedersen, Inge Søkilde

AU - Dervan, Peter

AU - McGoldrick, Alo

AU - Harrison, Michéle

AU - Ponchel, Frederique

AU - Speirs, Valerie

AU - Isaacs, John D.

AU - Gorey, Thomas

AU - McCann, Amanda

PY - 2002/6/1

Y1 - 2002/6/1

N2 - Neuraminidase initiates the hydrolysis of sialo-glycoconjugates by removing their terminal sialic acid residues. In humans, primary or secondary deficiency of this enzyme leads to two clinically similar neurodegenerative lysosomal storage disorders: sialidosis and galactosialidosis (GS). Mice nullizygous at the Neu1 locus develop clinical abnormalities reminiscent of early-onset sialidosis in children, including severe nephropathy, progressive edema, splenomegaly, kyphosis and urinary excretion of sialylated oligosaccharides. Although the sialidosis mouse model shares clinical and histopathological features with GS mice and GS patients, we have identified phenotypic abnormalities that seem specific for sialidosis mice. These include progressive deformity of the spine, high incidence of premature death, age-related extramedullary hematopoiesis, and lack of early degeneration of cerebellar Purkinje cells. The differences and similarities identified in these sialidosis and GS mice may help to better understand the pathophysiology of these diseases in children and to identify more targeted therapies for each of these diseases.

AB - Neuraminidase initiates the hydrolysis of sialo-glycoconjugates by removing their terminal sialic acid residues. In humans, primary or secondary deficiency of this enzyme leads to two clinically similar neurodegenerative lysosomal storage disorders: sialidosis and galactosialidosis (GS). Mice nullizygous at the Neu1 locus develop clinical abnormalities reminiscent of early-onset sialidosis in children, including severe nephropathy, progressive edema, splenomegaly, kyphosis and urinary excretion of sialylated oligosaccharides. Although the sialidosis mouse model shares clinical and histopathological features with GS mice and GS patients, we have identified phenotypic abnormalities that seem specific for sialidosis mice. These include progressive deformity of the spine, high incidence of premature death, age-related extramedullary hematopoiesis, and lack of early degeneration of cerebellar Purkinje cells. The differences and similarities identified in these sialidosis and GS mice may help to better understand the pathophysiology of these diseases in children and to identify more targeted therapies for each of these diseases.

UR - http://www.scopus.com/inward/record.url?scp=71749085538&partnerID=8YFLogxK

M3 - Article

C2 - 12023988

AN - SCOPUS:71749085538

VL - 11

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 12

ER -